Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.
暂无分享,去创建一个
[1] Matthias Stieß,et al. Mechanische Verfahrenstechnik 1 , 1992 .
[2] P. Gassmann,et al. Hydrosols : alternatives for the parenteral application of poorly water soluble drugs , 1994 .
[3] R. Müller,et al. Nanocrystals of Poorly Soluble Drugs for Oral Administration , 2003 .
[4] Barrett E. Rabinow,et al. Nanosuspensions in drug delivery , 2004, Nature Reviews Drug Discovery.
[5] N. Rasenack,et al. Dissolution Rate Enhancement by in Situ Micronization of Poorly Water-Soluble Drugs , 2002, Pharmaceutical Research.
[6] O. Kayser,et al. for Poorly Soluble and Poorly Bioavailable Drugs , 2003 .
[7] R. Müller,et al. Intravenous itraconazole emulsions produced by SolEmuls technology. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[8] R. Müller,et al. Formulation of intravenous carbamazepine emulsions by SolEmuls technology. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[9] C. Porter,et al. LIPID-BASED FORMULATIONS FOR ORAL ADMINISTRATION: OPPORTUNITIES FOR BIOAVAILABILITY ENHANCEMENT AND LIPOPROTEIN TARGETING OF LIPOPHILIC DRUGS , 2001, Journal of receptor and signal transduction research.
[10] C. Porter,et al. In vitro assessment of oral lipid based formulations. , 2001, Advanced drug delivery reviews.
[11] W. Higuchi,et al. Inhibition of sulfathiazole crystal growth by polyvinylpyrrolidone. , 1970, Journal of pharmaceutical sciences.
[12] R. Müller,et al. Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. , 2000, International journal of pharmaceutics.
[13] B. Müller,et al. Size controlled production of biodegradable microparticles with supercritical gases. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[14] W. Charman,et al. Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts. , 2000, Journal of pharmaceutical sciences.
[15] Mitra Mosharraf,et al. The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs , 1995 .
[16] O. Kayser,et al. DissoCubes—A Novel Formulation for Poorly Soluble and Poorly Bioavailable Drugs , 2002 .